← Back to headlines
Soleno Therapeutics Investor Sentiment Subdued Amid Growth Concerns
Investor sentiment for Soleno Therapeutics (SLNO) remains subdued, reflecting ongoing concerns about the company's growth prospects.
2 Apr, 13:39 — 2 Apr, 13:39
Sources
Showing 1 of 1 sources
